ID   PURA_ECOLI              Reviewed;         432 AA.
AC   P0A7D4; P12283; Q2M6C8;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   15-MAR-2017, entry version 119.
DE   RecName: Full=Adenylosuccinate synthetase {ECO:0000255|HAMAP-Rule:MF_00011};
DE            Short=AMPSase {ECO:0000255|HAMAP-Rule:MF_00011};
DE            Short=AdSS {ECO:0000255|HAMAP-Rule:MF_00011};
DE            EC=6.3.4.4 {ECO:0000255|HAMAP-Rule:MF_00011};
DE   AltName: Full=IMP--aspartate ligase {ECO:0000255|HAMAP-Rule:MF_00011};
GN   Name=purA {ECO:0000255|HAMAP-Rule:MF_00011}; Synonyms=adeK;
GN   OrderedLocusNames=b4177, JW4135;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 2-11.
RC   STRAIN=K12;
RX   PubMed=3058695;
RA   Wolfe S.A., Smith J.M.;
RT   "Nucleotide sequence and analysis of the purA gene encoding
RT   adenylosuccinate synthetase of Escherichia coli K12.";
RL   J. Biol. Chem. 263:19147-19153(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=7610040; DOI=10.1093/nar/23.12.2105;
RA   Burland V.D., Plunkett G. III, Sofia H.J., Daniels D.L.,
RA   Blattner F.R.;
RT   "Analysis of the Escherichia coli genome VI: DNA sequence of the
RT   region from 92.8 through 100 minutes.";
RL   Nucleic Acids Res. 23:2105-2119(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PROTEIN SEQUENCE OF 146-148, AND MUTAGENESIS OF ARG-148.
RX   PubMed=2061308;
RA   Dong Q., Liu F., Myers A.M., Fromm H.J.;
RT   "Evidence for an arginine residue at the substrate binding site of
RT   Escherichia coli adenylosuccinate synthetase as studied by chemical
RT   modification and site-directed mutagenesis.";
RL   J. Biol. Chem. 266:12228-12233(1991).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-10.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded
RT   in the genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [7]
RP   ACTIVE SITE LYS-141.
RX   PubMed=2108156;
RA   Dong Q., Fromm H.J.;
RT   "Chemical modification of adenylosuccinate synthetase from Escherichia
RT   coli by pyridoxal 5'-phosphate. Identification of an active site lysyl
RT   residue.";
RL   J. Biol. Chem. 265:6235-6240(1990).
RN   [8]
RP   MUTAGENESIS.
RX   PubMed=1733940;
RA   Liu F., Dong Q., Fromm H.J.;
RT   "Site-directed mutagenesis of the phosphate-binding consensus sequence
RT   in Escherichia coli adenylosuccinate synthetase.";
RL   J. Biol. Chem. 267:2388-2392(1992).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), AND SEQUENCE REVISION TO 417.
RX   PubMed=7490761; DOI=10.1006/jmbi.1995.0629;
RA   Silva M.M., Poland B.W., Hoffman C.R., Fromm H.J., Honzatko R.B.;
RT   "Refined crystal structures of unligated adenylosuccinate synthetase
RT   from Escherichia coli.";
RL   J. Mol. Biol. 254:431-446(1995).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH GDP; MAGNESIUM;
RP   SUBSTRATE ANALOG AND INHIBITOR.
RX   PubMed=8961938; DOI=10.1021/bi961758r;
RA   Poland B.W., Lee S.F., Subramanian M.V., Siehl D.L., Anderson R.J.,
RA   Fromm H.J., Honzatko R.B.;
RT   "Refined crystal structure of adenylosuccinate synthetase from
RT   Escherichia coli complexed with hydantocidin 5'-phosphate, GDP,
RT   HPO4(2-), Mg2+, and hadacidin.";
RL   Biochemistry 35:15753-15759(1996).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 2-431.
RX   PubMed=8663109; DOI=10.1074/jbc.271.26.15407;
RA   Poland B.W., Hou Z., Bruns C., Fromm H.J., Honzatko R.B.;
RT   "Refined crystal structures of guanine nucleotide complexes of
RT   adenylosuccinate synthetase from Escherichia coli.";
RL   J. Biol. Chem. 271:15407-15413(1996).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH GDP; IMP;
RP   MAGNESIUM AND SUBSTRATE ANALOG.
RX   PubMed=9000627; DOI=10.1006/jmbi.1996.0693;
RA   Poland B.W., Fromm H.J., Honzatko R.B.;
RT   "Crystal structures of adenylosuccinate synthetase from Escherichia
RT   coli complexed with GDP, IMP hadacidin, NO3-, and Mg2+.";
RL   J. Mol. Biol. 264:1013-1027(1996).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 2-431.
RX   PubMed=8790347; DOI=10.1073/pnas.93.18.9431;
RA   Fonne-Pfister R., Chemla P., Ward E., Girardet M., Kreuz K.E.,
RA   Honzatko R.B., Fromm H.J., Schaer H.-P., Gruetter M.G.,
RA   Cowan-Jacob S.W.;
RT   "The mode of action and the structure of a herbicide in complex with
RT   its target: binding of activated hydantocidin to the feedback
RT   regulation site of adenylosuccinate synthetase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:9431-9436(1996).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 2-431.
RX   PubMed=9182542; DOI=10.1074/jbc.272.24.15200;
RA   Poland B.W., Bruns C., Fromm H.J., Honzatko R.B.;
RT   "Entrapment of 6-thiophosphoryl-IMP in the active site of crystalline
RT   adenylosuccinate synthetase from Escherichia coli.";
RL   J. Biol. Chem. 272:15200-15205(1997).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS).
RX   PubMed=10556888;
RX   DOI=10.1002/(SICI)1521-3773(19991102)38:21<3159::AID-ANIE3159>3.0.CO;2-2;
RA   Hanessian S., Lu P.P., Sanceau J.Y., Chemla P., Gohda K.,
RA   Fonne-Pfister R., Prade L., Cowan-Jacob S.W.;
RT   "An enzyme-bound bisubstrate hybrid inhibitor of adenylosuccinate
RT   synthetase.";
RL   Angew. Chem. Int. Ed. Engl. 38:3159-3162(1999).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF WILD-TYPE AND MUTANTS GLN-17;
RP   LEU-144 AND LEU-304 IN COMPLEX WITH GTP; IMP; MAGNESIUM AND SUBSTRATE
RP   ANALOG.
RX   PubMed=10346917; DOI=10.1021/bi990159s;
RA   Choe J.Y., Poland B.W., Fromm H.J., Honzatko R.B.;
RT   "Mechanistic implications from crystalline complexes of wild-type and
RT   mutant adenylosuccinate synthetases from Escherichia coli.";
RL   Biochemistry 38:6953-6961(1999).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=10364182; DOI=10.1074/jbc.274.25.17505;
RA   Hou Z., Cashel M., Fromm H.J., Honzatko R.B.;
RT   "Effectors of the stringent response target the active site of
RT   Escherichia coli adenylosuccinate synthetase.";
RL   J. Biol. Chem. 274:17505-17510(1999).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 1-432.
RX   PubMed=11741996; DOI=10.1074/jbc.M109561200;
RA   Hou Z., Wang W., Fromm H.J., Honzatko R.B.;
RT   "IMP alone organizes the active site of adenylosuccinate synthetase
RT   from Escherichia coli.";
RL   J. Biol. Chem. 277:5970-5976(2002).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-431.
RX   PubMed=16981730; DOI=10.1021/bi0607498;
RA   Iancu C.V., Zhou Y., Borza T., Fromm H.J., Honzatko R.B.;
RT   "Cavitation as a mechanism of substrate discrimination by
RT   adenylosuccinate synthetases.";
RL   Biochemistry 45:11703-11711(2006).
CC   -!- FUNCTION: Plays an important role in the de novo pathway of purine
CC       nucleotide biosynthesis. Catalyzes the first committed step in the
CC       biosynthesis of AMP from IMP. {ECO:0000255|HAMAP-Rule:MF_00011}.
CC   -!- CATALYTIC ACTIVITY: GTP + IMP + L-aspartate = GDP + phosphate +
CC       N(6)-(1,2-dicarboxyethyl)-AMP. {ECO:0000255|HAMAP-Rule:MF_00011}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 1 Mg(2+) ion per subunit.;
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway;
CC       AMP from IMP: step 1/2. {ECO:0000255|HAMAP-Rule:MF_00011}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_00011,
CC       ECO:0000269|PubMed:10346917, ECO:0000269|PubMed:8961938,
CC       ECO:0000269|PubMed:9000627}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the adenylosuccinate synthetase family.
CC       {ECO:0000255|HAMAP-Rule:MF_00011}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04199; AAA24446.1; -; Genomic_DNA.
DR   EMBL; U14003; AAA97073.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC77134.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE78178.1; -; Genomic_DNA.
DR   PIR; S56402; AJECDS.
DR   RefSeq; NP_418598.1; NC_000913.3.
DR   RefSeq; WP_000527955.1; NZ_LN832404.1.
DR   PDB; 1ADE; X-ray; 2.00 A; A/B=2-432.
DR   PDB; 1ADI; X-ray; 2.50 A; A/B=2-432.
DR   PDB; 1CG0; X-ray; 2.50 A; A=2-432.
DR   PDB; 1CG1; X-ray; 2.50 A; A=2-432.
DR   PDB; 1CG3; X-ray; 2.50 A; A=2-432.
DR   PDB; 1CG4; X-ray; 2.50 A; A=2-432.
DR   PDB; 1CH8; X-ray; 2.50 A; A=2-432.
DR   PDB; 1CIB; X-ray; 2.30 A; A=2-432.
DR   PDB; 1GIM; X-ray; 2.50 A; A=2-432.
DR   PDB; 1GIN; X-ray; 2.80 A; A=2-432.
DR   PDB; 1HON; X-ray; 2.30 A; A/B=2-432.
DR   PDB; 1HOO; X-ray; 2.30 A; A/B=2-432.
DR   PDB; 1HOP; X-ray; 2.30 A; A/B=2-432.
DR   PDB; 1JUY; X-ray; 2.50 A; A=2-432.
DR   PDB; 1KJX; X-ray; 2.60 A; A=1-432.
DR   PDB; 1KKB; X-ray; 2.60 A; A=1-432.
DR   PDB; 1KKF; X-ray; 2.60 A; A=1-432.
DR   PDB; 1KSZ; X-ray; 2.80 A; A=2-432.
DR   PDB; 1NHT; X-ray; 2.50 A; A=2-432.
DR   PDB; 1QF4; X-ray; 2.20 A; A=2-432.
DR   PDB; 1QF5; X-ray; 2.00 A; A=2-432.
DR   PDB; 1SON; X-ray; 2.55 A; A=2-432.
DR   PDB; 1SOO; X-ray; 2.60 A; A=2-432.
DR   PDB; 2GCQ; X-ray; 2.00 A; A=2-432.
DR   PDBsum; 1ADE; -.
DR   PDBsum; 1ADI; -.
DR   PDBsum; 1CG0; -.
DR   PDBsum; 1CG1; -.
DR   PDBsum; 1CG3; -.
DR   PDBsum; 1CG4; -.
DR   PDBsum; 1CH8; -.
DR   PDBsum; 1CIB; -.
DR   PDBsum; 1GIM; -.
DR   PDBsum; 1GIN; -.
DR   PDBsum; 1HON; -.
DR   PDBsum; 1HOO; -.
DR   PDBsum; 1HOP; -.
DR   PDBsum; 1JUY; -.
DR   PDBsum; 1KJX; -.
DR   PDBsum; 1KKB; -.
DR   PDBsum; 1KKF; -.
DR   PDBsum; 1KSZ; -.
DR   PDBsum; 1NHT; -.
DR   PDBsum; 1QF4; -.
DR   PDBsum; 1QF5; -.
DR   PDBsum; 1SON; -.
DR   PDBsum; 1SOO; -.
DR   PDBsum; 2GCQ; -.
DR   ProteinModelPortal; P0A7D4; -.
DR   SMR; P0A7D4; -.
DR   BioGrid; 4262696; 26.
DR   BioGrid; 852987; 1.
DR   DIP; DIP-36219N; -.
DR   IntAct; P0A7D4; 2.
DR   MINT; MINT-1286548; -.
DR   STRING; 511145.b4177; -.
DR   DrugBank; DB02666; (C8-R)-Hydantocidin 5'-Phosphate.
DR   DrugBank; DB04460; (C8-S)-Hydantocidin 5'-Phosphate.
DR   DrugBank; DB02954; (Carboxyhydroxyamino)Ethanoic Acid.
DR   DrugBank; DB02682; 2-Deamino-6-Deoxy-6thiophosphite-5'-Phosphate Guanosine.
DR   DrugBank; DB03146; 2-Deazo-6-Thiophosphate Guanosine-5'-Monophosphate.
DR   DrugBank; DB02836; Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate.
DR   DrugBank; DB04315; Guanosine-5'-Diphosphate.
DR   DrugBank; DB02109; Hadacidin.
DR   DrugBank; DB02493; Hydantocidin-5'-Phosphate.
DR   DrugBank; DB04566; Inosinic Acid.
DR   SWISS-2DPAGE; P0A7D4; -.
DR   EPD; P0A7D4; -.
DR   PaxDb; P0A7D4; -.
DR   PRIDE; P0A7D4; -.
DR   EnsemblBacteria; AAC77134; AAC77134; b4177.
DR   EnsemblBacteria; BAE78178; BAE78178; BAE78178.
DR   GeneID; 948695; -.
DR   KEGG; ecj:JW4135; -.
DR   KEGG; eco:b4177; -.
DR   PATRIC; 32123927; VBIEscCol129921_4308.
DR   EchoBASE; EB0783; -.
DR   EcoGene; EG10790; purA.
DR   eggNOG; ENOG4105C91; Bacteria.
DR   eggNOG; COG0104; LUCA.
DR   HOGENOM; HOG000260959; -.
DR   InParanoid; P0A7D4; -.
DR   KO; K01939; -.
DR   OMA; FHHAKPI; -.
DR   PhylomeDB; P0A7D4; -.
DR   BioCyc; EcoCyc:ADENYLOSUCCINATE-SYN-MONOMER; -.
DR   BioCyc; MetaCyc:ADENYLOSUCCINATE-SYN-MONOMER; -.
DR   BRENDA; 6.3.4.4; 2026.
DR   SABIO-RK; P0A7D4; -.
DR   UniPathway; UPA00075; UER00335.
DR   EvolutionaryTrace; P0A7D4; -.
DR   PRO; PR:P0A7D4; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0004019; F:adenylosuccinate synthase activity; IDA:EcoCyc.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044208; P:'de novo' AMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0046086; P:adenosine biosynthetic process; IMP:EcoliWiki.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEP:EcoliWiki.
DR   GO; GO:0046040; P:IMP metabolic process; IBA:GO_Central.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; IDA:EcoliWiki.
DR   GO; GO:0006164; P:purine nucleotide biosynthetic process; IMP:EcoCyc.
DR   CDD; cd03108; AdSS; 1.
DR   HAMAP; MF_00011; Adenylosucc_synth; 1.
DR   InterPro; IPR018220; Adenylosuccin_syn_GTP-bd.
DR   InterPro; IPR033128; Adenylosuccin_syn_Lys_AS.
DR   InterPro; IPR001114; Adenylosuccinate_synthetase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11846; PTHR11846; 1.
DR   Pfam; PF00709; Adenylsucc_synt; 1.
DR   SMART; SM00788; Adenylsucc_synt; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00184; purA; 1.
DR   PROSITE; PS01266; ADENYLOSUCCIN_SYN_1; 1.
DR   PROSITE; PS00513; ADENYLOSUCCIN_SYN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   GTP-binding; Ligase; Magnesium; Metal-binding; Nucleotide-binding;
KW   Purine biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:3058695,
FT                                ECO:0000269|PubMed:9298646}.
FT   CHAIN         2    432       Adenylosuccinate synthetase.
FT                                /FTId=PRO_0000095174.
FT   NP_BIND      13     19       GTP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917}.
FT   NP_BIND      41     43       GTP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917}.
FT   NP_BIND     332    334       GTP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917}.
FT   NP_BIND     415    417       GTP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917}.
FT   REGION       14     17       IMP binding.
FT   REGION       39     42       IMP binding.
FT   REGION      300    306       Substrate binding.
FT   ACT_SITE     14     14       Proton acceptor.
FT   ACT_SITE     42     42       Proton donor.
FT   METAL        14     14       Magnesium. {ECO:0000255|HAMAP-
FT                                Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917,
FT                                ECO:0000269|PubMed:8961938,
FT                                ECO:0000269|PubMed:9000627}.
FT   METAL        41     41       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917,
FT                                ECO:0000269|PubMed:8961938,
FT                                ECO:0000269|PubMed:9000627}.
FT   BINDING     130    130       IMP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917,
FT                                ECO:0000269|PubMed:9000627}.
FT   BINDING     144    144       IMP; shared with dimeric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917,
FT                                ECO:0000269|PubMed:9000627}.
FT   BINDING     225    225       IMP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917,
FT                                ECO:0000269|PubMed:9000627}.
FT   BINDING     240    240       IMP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917,
FT                                ECO:0000269|PubMed:9000627}.
FT   BINDING     304    304       IMP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917,
FT                                ECO:0000269|PubMed:9000627}.
FT   BINDING     306    306       GTP. {ECO:0000255|HAMAP-Rule:MF_00011,
FT                                ECO:0000269|PubMed:10346917}.
FT   MUTAGEN      13     13       G->V: Significant reduction in activity.
FT                                {ECO:0000269|PubMed:1733940}.
FT   MUTAGEN      16     16       G->V: Significant reduction in activity.
FT                                {ECO:0000269|PubMed:1733940}.
FT   MUTAGEN      17     17       K->Q: Reduces catalytic efficiency by
FT                                50%. {ECO:0000269|PubMed:1733940}.
FT   MUTAGEN      18     18       G->V: Significant reduction in activity.
FT                                {ECO:0000269|PubMed:1733940}.
FT   MUTAGEN      19     19       K->R: Significant reduction in activity.
FT                                {ECO:0000269|PubMed:1733940}.
FT   MUTAGEN      20     20       I->T: Significant reduction in activity.
FT                                {ECO:0000269|PubMed:1733940}.
FT   MUTAGEN     141    141       K->I: Total loss of activity.
FT                                {ECO:0000269|PubMed:1733940}.
FT   MUTAGEN     144    144       R->L: Does not reduce catalytic
FT                                efficiency. {ECO:0000269|PubMed:1733940}.
FT   MUTAGEN     148    148       R->L: Reduced activity.
FT                                {ECO:0000269|PubMed:2061308}.
FT   MUTAGEN     304    304       R->L: Reduces catalytic efficiency by
FT                                87%. {ECO:0000269|PubMed:1733940}.
FT   CONFLICT    417    417       G -> D (in Ref. 1; AAA24446).
FT                                {ECO:0000305}.
FT   STRAND        4     13       {ECO:0000244|PDB:1ADE}.
FT   HELIX        17     24       {ECO:0000244|PDB:1ADE}.
FT   TURN         25     27       {ECO:0000244|PDB:1ADE}.
FT   STRAND       29     33       {ECO:0000244|PDB:1ADE}.
FT   STRAND       42     46       {ECO:0000244|PDB:1ADE}.
FT   STRAND       49     56       {ECO:0000244|PDB:1ADE}.
FT   HELIX        58     61       {ECO:0000244|PDB:1ADE}.
FT   STRAND       62     64       {ECO:0000244|PDB:1HOO}.
FT   STRAND       66     69       {ECO:0000244|PDB:1ADE}.
FT   HELIX        77     89       {ECO:0000244|PDB:1ADE}.
FT   HELIX        94     97       {ECO:0000244|PDB:1ADE}.
FT   STRAND       98    100       {ECO:0000244|PDB:1ADE}.
FT   STRAND      104    106       {ECO:0000244|PDB:1GIM}.
FT   HELIX       109    120       {ECO:0000244|PDB:1ADE}.
FT   HELIX       123    125       {ECO:0000244|PDB:1ADE}.
FT   STRAND      126    128       {ECO:0000244|PDB:1HOP}.
FT   STRAND      131    133       {ECO:0000244|PDB:1QF5}.
FT   HELIX       134    142       {ECO:0000244|PDB:1ADE}.
FT   HELIX       149    153       {ECO:0000244|PDB:1ADE}.
FT   HELIX       155    175       {ECO:0000244|PDB:1ADE}.
FT   HELIX       184    199       {ECO:0000244|PDB:1ADE}.
FT   HELIX       205    215       {ECO:0000244|PDB:1ADE}.
FT   STRAND      219    222       {ECO:0000244|PDB:1ADE}.
FT   HELIX       227    229       {ECO:0000244|PDB:1ADE}.
FT   TURN        231    233       {ECO:0000244|PDB:1ADE}.
FT   STRAND      234    238       {ECO:0000244|PDB:1ADI}.
FT   HELIX       246    248       {ECO:0000244|PDB:1ADE}.
FT   HELIX       249    253       {ECO:0000244|PDB:1ADE}.
FT   HELIX       257    259       {ECO:0000244|PDB:1ADE}.
FT   STRAND      262    273       {ECO:0000244|PDB:1ADE}.
FT   STRAND      275    277       {ECO:0000244|PDB:1ADE}.
FT   HELIX       286    295       {ECO:0000244|PDB:1ADE}.
FT   TURN        300    302       {ECO:0000244|PDB:1ADE}.
FT   STRAND      307    309       {ECO:0000244|PDB:1ADE}.
FT   HELIX       313    323       {ECO:0000244|PDB:1ADE}.
FT   STRAND      327    331       {ECO:0000244|PDB:1ADE}.
FT   HELIX       333    336       {ECO:0000244|PDB:1ADE}.
FT   STRAND      340    349       {ECO:0000244|PDB:1ADE}.
FT   STRAND      355    358       {ECO:0000244|PDB:1ADE}.
FT   HELIX       363    365       {ECO:0000244|PDB:1QF5}.
FT   HELIX       366    368       {ECO:0000244|PDB:1ADE}.
FT   STRAND      370    377       {ECO:0000244|PDB:1ADE}.
FT   HELIX       389    391       {ECO:0000244|PDB:1ADE}.
FT   HELIX       394    407       {ECO:0000244|PDB:1ADE}.
FT   STRAND      411    415       {ECO:0000244|PDB:1ADE}.
FT   STRAND      417    419       {ECO:0000244|PDB:1ADE}.
FT   STRAND      422    427       {ECO:0000244|PDB:1ADE}.
FT   TURN        429    431       {ECO:0000244|PDB:1ADE}.
SQ   SEQUENCE   432 AA;  47345 MW;  AAA862CA0F80DA70 CRC64;
     MGNNVVVLGT QWGDEGKGKI VDLLTERAKY VVRYQGGHNA GHTLVINGEK TVLHLIPSGI
     LRENVTSIIG NGVVLSPAAL MKEMKELEDR GIPVRERLLL SEACPLILDY HVALDNAREK
     ARGAKAIGTT GRGIGPAYED KVARRGLRVG DLFDKETFAE KLKEVMEYHN FQLVNYYKAE
     AVDYQKVLDD TMAVADILTS MVVDVSDLLD QARQRGDFVM FEGAQGTLLD IDHGTYPYVT
     SSNTTAGGVA TGSGLGPRYV DYVLGILKAY STRVGAGPFP TELFDETGEF LCKQGNEFGA
     TTGRRRRTGW LDTVAVRRAV QLNSLSGFCL TKLDVLDGLK EVKLCVAYRM PDGREVTTTP
     LAADDWKGVE PIYETMPGWS ESTFGVKDRS GLPQAALNYI KRIEELTGVP IDIISTGPDR
     TETMILRDPF DA
//
